Linc

Linc Earnings Yield

The Earnings Yield of Linc (LINC.ST) as of Nov 20, 2026 is -9.58 %. In the previous year, Earnings Yield was 31.22 % — a change of -130.70% (lower).

Earnings Yield

-9.58 %

YoY

-130.70%

Last updated:

Earnings Yield of Linc is 2025 -9.58 % . Earnings Yield of Linc was 2024 31.22 % . It decreases by -130.70% lower compared to the previous year.

The Linc Earnings Yield history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Earnings Yield
Date
Earnings Yield
Jan 1, 2018
7.58 SEK
Jan 1, 2019
14.30 SEK
Jan 1, 2020
19.98 SEK
Jan 1, 2021
-0.72 SEK
Jan 1, 2022
-17.35 SEK
Jan 1, 2023
14.86 SEK
Jan 1, 2024
31.22 SEK
Jan 1, 2025
-9.58 SEK
The Linc Earnings Yield history
YEAREarnings YieldYoY
-9.58 %-130.70%
31.22 %+110.12%
14.86 %-185.64%
-17.35 %+2,308.79%
-0.72 %-103.60%
19.98 %+39.75%
14.30 %+88.71%
7.58 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Linc Stock analysis

What does Linc do? Linc AB generates revenue through long-term share ownership in Nordic life science companies, focusing on pharmaceutical and medical technology sectors. The company invests in both private and public firms, including early-stage drug development and operational medical technology companies. Linc Invest actively supports portfolio companies by collaborating with management, founders, and boards to unlock growth potential and drive expansion. Its industrial network enables strategic participation in nomination committees and development planning. The firm targets Nordic life science product-oriented companies, prioritizing pharmaceuticals and medical technology. Investments span research and operational phases, with drug development typically occurring earlier than in medical technology. Linc AB maintains a hands-on approach as a long-term owner, leveraging its network to assist portfolio companies in achieving ambitious development goals. Linc AB's business model centers on active ownership and strategic partnerships within the Nordic life science ecosystem. It focuses on companies with strong product pipelines, particularly in pharmaceuticals, where investments often occur during initial development stages. The company's role as a supportive shareholder drives value creation through collaborative governance and targeted expansion strategies. Linc is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Linc stock

Earnings Yield of Linc is -9.58 % in 2025.

Earnings Yield of Linc changed from 31.22 % to -9.58 %, representing a -130.70% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Earnings Yield Linc since 2006 – with annual values, charts, and detailed analysis.

Earnings Yield is the inverse of the P/E ratio. It shows the percentage of each dollar invested that was earned by the company. Higher earnings yield indicates better value.

To evaluate Earnings Yield's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Earnings Yield.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Earnings Yield's Linc with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Linc

All Key Metrics — Linc